BR9813465A - Polissacarìdeos modificados que exibem reconhecimento biológico alterado - Google Patents

Polissacarìdeos modificados que exibem reconhecimento biológico alterado

Info

Publication number
BR9813465A
BR9813465A BR9813465-5A BR9813465A BR9813465A BR 9813465 A BR9813465 A BR 9813465A BR 9813465 A BR9813465 A BR 9813465A BR 9813465 A BR9813465 A BR 9813465A
Authority
BR
Brazil
Prior art keywords
altered biological
modified polysaccharides
biological recognition
exhibit altered
polysaccharides
Prior art date
Application number
BR9813465-5A
Other languages
English (en)
Inventor
Bo E Hedlund
Thomas P Weber
Paul R Dragsten
Gregory J Hanson
Philip E Hallaway
Original Assignee
Biomed Frontiers Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biomed Frontiers Inc filed Critical Biomed Frontiers Inc
Publication of BR9813465A publication Critical patent/BR9813465A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0021—Dextran, i.e. (alpha-1,4)-D-glucan; Derivatives thereof, e.g. Sephadex, i.e. crosslinked dextran
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/718—Starch or degraded starch, e.g. amylose, amylopectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/721—Dextrans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/547—Chelates, e.g. Gd-DOTA or Zinc-amino acid chelates; Chelate-forming compounds, e.g. DOTA or ethylenediamine being covalently linked or complexed to the pharmacologically- or therapeutically-active agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B31/00—Preparation of derivatives of starch
    • C08B31/18—Oxidised starch
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B31/00—Preparation of derivatives of starch
    • C08B31/18—Oxidised starch
    • C08B31/185—Derivatives of oxidised starch, e.g. crosslinked oxidised starch

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Materials Engineering (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Patente de Invenção: "POLISSACARìDEOS MODIFICADOS QUE EXIBEM RECONHECIMENTO BIOLóGICO ALTERADO". A invenção refere-se a polissacarídeos, conjugados de polissacarídeos com propriedades biológicas alteradas, e a métodos para produzir estes polissacarídeos e conjugados.
BR9813465-5A 1997-12-09 1998-12-09 Polissacarìdeos modificados que exibem reconhecimento biológico alterado BR9813465A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US6907997P 1997-12-09 1997-12-09
US6909597P 1997-12-11 1997-12-11
PCT/US1998/026132 WO1999029328A1 (en) 1997-12-09 1998-12-09 Modified polysaccharides exhibiting altered biological recognition

Publications (1)

Publication Number Publication Date
BR9813465A true BR9813465A (pt) 2002-01-22

Family

ID=26749664

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9813465-5A BR9813465A (pt) 1997-12-09 1998-12-09 Polissacarìdeos modificados que exibem reconhecimento biológico alterado

Country Status (12)

Country Link
US (1) US6479468B1 (pt)
EP (1) EP1037642B9 (pt)
JP (1) JP4435412B2 (pt)
AT (1) ATE425758T1 (pt)
AU (1) AU761784B2 (pt)
BR (1) BR9813465A (pt)
CA (1) CA2314716C (pt)
DE (1) DE69840673D1 (pt)
DK (1) DK1037642T3 (pt)
ES (1) ES2325005T3 (pt)
TR (1) TR200001682T2 (pt)
WO (1) WO1999029328A1 (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6780852B2 (en) 1997-12-09 2004-08-24 Bo E. Hedlund Modified polysaccharides exhibiting altered biological recognition
US20030236224A1 (en) * 1997-12-09 2003-12-25 Hedlund Bo E. Modified polysaccharides exhibiting altered biological recognition
US7538097B2 (en) 2000-09-26 2009-05-26 Halozyme, Inc. Inhibition of antigen presentation with poorly catabolized polymers
EP1707632A1 (de) * 2005-04-01 2006-10-04 Bayer CropScience GmbH Phosphorylierte waxy-Kartoffelstärke
US7709001B2 (en) * 2005-04-08 2010-05-04 Wyeth Llc Multivalent pneumococcal polysaccharide-protein conjugate composition
ES2812523T3 (es) 2009-09-30 2021-03-17 Glaxosmithkline Biologicals Sa Conjugación de polisacáridos capsulares de Staphylococcus aureus de tipo 5 y de tipo 8
ES2846848T3 (es) * 2015-10-26 2021-07-29 Harvard College Polisacáridos reducidos y oxidados y métodos de uso de los mismos
WO2018229117A1 (en) * 2017-06-13 2018-12-20 Merz Pharma Gmbh & Co. Kgaa Mixing nozzle, application device, kit and method using the mixing nozzle or application device
CN110809401B (zh) * 2017-07-06 2022-11-15 拜耳股份公司 杂草控制装置

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB977694A (en) * 1959-12-23 1964-12-09 Chugai Pharmaceutical Co Ltd Starch derivatives
DE1186076B (de) 1960-10-11 1965-01-28 Ciba Geigy Verfahren zur Gewinnung komplexmetallfreier Ferrioxamine
JPS5634701A (en) * 1979-08-29 1981-04-07 Meito Sangyo Kk Beta-1,3-glucan, its preparation and use
US4419365A (en) 1981-12-21 1983-12-06 Ciba-Geigy Corporation Method of treating Alzheimer's disease
US4863964A (en) 1985-07-02 1989-09-05 Biomedical Frontiers, Inc. Method for the stabilization of deferoxamine to chelate free ions in physiological fluid
US5217998A (en) 1985-07-02 1993-06-08 Biomedical Frontiers, Inc. Composition for the stabilization of deferoxamine to chelate free ions in physiological fluid
US4863961A (en) * 1985-11-25 1989-09-05 G. D. Searle & Co. Tetraenyl prostaglandins
US4987253A (en) 1988-09-19 1991-01-22 University Of Florida Method for the synthesis of desferrioxamine B and analogs thereof
US5268165A (en) 1990-10-16 1993-12-07 Biomedical Frontiers, Inc. Polymer-deferoxamine-ferric iron adducts for use in magnetic resonance imaging
US5493053A (en) 1994-12-21 1996-02-20 University Of Florida Research Foundation, Inc. Method for preparing desferrioxamine B and homologs thereof
US5811510A (en) * 1995-04-14 1998-09-22 General Hospital Corporation Biodegradable polyacetal polymers and methods for their formation and use
US5847110A (en) 1997-08-15 1998-12-08 Biomedical Frontiers, Inc. Method of reducing a schiff base

Also Published As

Publication number Publication date
US6479468B1 (en) 2002-11-12
ES2325005T3 (es) 2009-08-21
EP1037642B1 (en) 2009-03-18
CA2314716A1 (en) 1999-06-17
AU761784B2 (en) 2003-06-12
DE69840673D1 (de) 2009-04-30
JP4435412B2 (ja) 2010-03-17
ATE425758T1 (de) 2009-04-15
DK1037642T3 (da) 2009-07-06
CA2314716C (en) 2009-02-03
WO1999029328A1 (en) 1999-06-17
AU1719799A (en) 1999-06-28
EP1037642B9 (en) 2010-10-13
TR200001682T2 (tr) 2001-02-21
JP2001525369A (ja) 2001-12-11
EP1037642A1 (en) 2000-09-27

Similar Documents

Publication Publication Date Title
DE69830326D1 (de) Iminbildende polysaccharide, deren herstellung und verwendung als zusatzmittel und immunstimulierende mittel
ES2110386T3 (es) Conjugados de interferon.
CY1114197T1 (el) Μεθοδος διαμορφωσης της δραστικοτητας λειτουργικων ανοσομοριων
DE69914928D1 (de) Polymerkomplexe von glukuronoglukanen
DK0955950T3 (da) Fladtrådsstent
ES2151277T3 (es) Composiciones que comprenden conjugados de acido cis-docosahexaenoico y taxotere.
BR0015611A (pt) Processo de limpeza que utiliza ondas ultra-sÈnicas
NO990497L (no) Modifiserte oligosakkarider
ES2174895T3 (es) Combinaciones metalicas complejas con contenido en carbenos heterociclicos.
DK1779725T3 (da) Teksturerede cellulose- og lignocellulosematerialer samt deraf fremstillede sammensætninger og kompositter
ES2128573T3 (es) Derivados de heparina con actividad antimetastatica.
ATE220136T1 (de) Kardierbare doppelglasfasermischung
BR9813465A (pt) Polissacarìdeos modificados que exibem reconhecimento biológico alterado
DE60113445D1 (de) Substanzen mit verzweigten linkermolekülen
BR9907025B1 (pt) Polissacarídeos sintéticos e uso dos mesmos
DK1220852T3 (da) Substituerede diazepaner
DE60037510D1 (de) Modifizierte polysaccharide mit amphiphilen einheiten
BR0013221A (pt) Chá preto de folha
ES2177722T3 (es) Electrodo de carbono.
TR199900430T2 (xx) �kameli 1,2,3,4-tetrahidro-2-dibenzofuranaminler ve 2-aminosiklohepta$b] benzofuranlar.
ES2196802T3 (es) Lactatos de citronelilo y/o de dihidrocitronelilo, su preparacion y su utilizacion.
ATE298373T1 (de) Immunstimulierende phellinus ssp. polysaccharid und verwendung
HUP0001100A2 (hu) Szklerózis elleni hatású specifikus zsiradék
ATA220896A (de) Ausziehführung für schubkästen o.dgl.
ES2183947T3 (es) Mutantes que producen un potencializador de la actividad pesticida de un bacillus.

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PRESENTE PEDIDO, POI A MATERIA REIVINDICADA NAO ATENDE AO REQUISITO DE ATIVIDADE INVENTIVA ART. 8O E 13 AD LPI.

B12B Appeal against refusal [chapter 12.2 patent gazette]
B15K Others concerning applications: alteration of classification

Ipc: C08B 37/02 (2006.01), A61K 31/718 (2006.0